<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>11(1)</volume><submitter>Abdulmalek S</submitter><pubmed_abstract>The present study was carried out to investigate the therapeutic effect of synthesized naturally compounds, curcumin nanoparticles (CurNPs) and metal oxide, zinc oxide nanoparticles (ZnONPs) on a high-fat diet (HFD)/streptozotocin (STZ)-induced hepatic and pancreatic pathophysiology in type 2 diabetes mellitus (T2DM) via measuring AKT pathway and MAPK pathway. T2DM rats were intraperitoneally injected with a low dose of 35 mg/kg STZ after being fed by HFD for 8 weeks. Then the rats have orally received treatments for 6 weeks. HFD/STZ-induced hepatic inflammation, reflected by increased phosphorylation of p38-MAPK pathway's molecules, was significantly decreased after nanoparticle supplementation. In addition, both nanoparticles significantly alleviated the decreased phosphorylation of AKT </pubmed_abstract><journal>Scientific reports</journal><pagination>20677</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8526574</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Ameliorative effect of curcumin and zinc oxide nanoparticles on multiple mechanisms in obese rats with induced type 2 diabetes.</pubmed_title><pmcid>PMC8526574</pmcid><pubmed_authors>Balbaa M</pubmed_authors><pubmed_authors>Awad D</pubmed_authors><pubmed_authors>Eldala A</pubmed_authors><pubmed_authors>Abdulmalek S</pubmed_authors></additional><is_claimable>false</is_claimable><name>Ameliorative effect of curcumin and zinc oxide nanoparticles on multiple mechanisms in obese rats with induced type 2 diabetes.</name><description>The present study was carried out to investigate the therapeutic effect of synthesized naturally compounds, curcumin nanoparticles (CurNPs) and metal oxide, zinc oxide nanoparticles (ZnONPs) on a high-fat diet (HFD)/streptozotocin (STZ)-induced hepatic and pancreatic pathophysiology in type 2 diabetes mellitus (T2DM) via measuring AKT pathway and MAPK pathway. T2DM rats were intraperitoneally injected with a low dose of 35 mg/kg STZ after being fed by HFD for 8 weeks. Then the rats have orally received treatments for 6 weeks. HFD/STZ-induced hepatic inflammation, reflected by increased phosphorylation of p38-MAPK pathway's molecules, was significantly decreased after nanoparticle supplementation. In addition, both nanoparticles significantly alleviated the decreased phosphorylation of AKT </description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Oct</publication><modification>2025-04-21T14:51:30.648Z</modification><creation>2025-04-21T14:51:30.648Z</creation></dates><accession>S-EPMC8526574</accession><cross_references><pubmed>34667196</pubmed><doi>10.1038/s41598-021-00108-w</doi></cross_references></HashMap>